DCTH:NASDAQ
Delcath Systems Inc
10,84Â $
arrow_upward
+1,88%(+0,20) 1 p
10,80Â $
arrow_downward
−0,37% (−0,040)bedtimePärast tööaega
Suletud: 24. apr, 16:00:01 GMT −4 · USD
search
Kõik sĂ¼mbolid
1 p
5 p
1 kuu
6 kuud
YTD
1 a
5 a
MAX
| SĂ¼mbol | Hind | Muutus | % muutus |
|---|
insights_autoĂœksuse DCTH põhistatistika genereerimine…
Ava
10,67Â $
Kõrge
10,90Â $
Madal
10,50Â $
Turu kapit.
373,49Â mln
Keskm. maht
314,26Â tuh
Maht
210,64Â tuh
Hinna ja tulu suhe
160,26
52 näd kõrgeim
18,23Â $
52 näd madalaim
8,12Â $
Aktsiatulu
0,07Â $
Beeta
0,44
Käibivad aktsiad
34,46Â mln
Töötajate arv
156
Uudised
Erinevatest veebiallikatest
Stock Traders Daily
·
1 päeva eest
How Delcath Systems Inc. (DCTH) Affects Rotational Strategy Timing
Profiil
Delcath Systems, Inc. is a publicly traded specialty pharmaceutical and medical device company, that develops percutaneous perfusion technologies for the targeted administration of high-dose chemotherapeutic agents to specific organs or regions of the body. Based in Queensbury, New York, the company has an intellectual property portfolio consisting of 28 patents worldwide. Delcath's Percutaneous Hepatic Perfusion is currently undergoing Phase II and Phase III trials against tumors in the liver. Delcath has a Cooperative Research and Development Agreement with the National Cancer Institute and has received Fast Track and a Special Protocol Assessment from the Food and Drug Administration for its use of melphalan in treating unresectable liver tumors. PHP, also known as the Delcath System, is tested for the treatment of metastatic melanoma in the liver and for primary liver cancer and metastatic hepatic malignancies from neuroendocrine cancers and adenocarcinomas, as well as patients with melanoma who previously received isolated perfusion. Chemotherapy is usually delivered intravenously, although a number of agents can be administered orally. Wikipedia
Teave Ă¼ksuse Delcath Systems Inc kohta
TegevjuhtGerard Michel
Töötajad156
Asutatud1988
PeakontoridQueensbury, New Yorgi osariik, Ameerika Ăœhendriigid
Sektor-
Veebisaitdelcath.com
AI genereeritud sisu võib sisaldada vigu. Lisateave